These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 24862241)
1. Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors. Queralto N; Berliner AN; Goldsmith B; Martino R; Rhodes P; Lim SH J Breath Res; 2014 Jun; 8(2):027112. PubMed ID: 24862241 [TBL] [Abstract][Full Text] [Related]
2. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis. Sun X; Shao K; Wang T Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028 [TBL] [Abstract][Full Text] [Related]
3. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening. Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337 [TBL] [Abstract][Full Text] [Related]
4. Progress in the development of volatile exhaled breath signatures of lung cancer. Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541 [TBL] [Abstract][Full Text] [Related]
5. Prospects and Challenges of Volatile Organic Compound Sensors in Human Healthcare. Jalal AH; Alam F; Roychoudhury S; Umasankar Y; Pala N; Bhansali S ACS Sens; 2018 Jul; 3(7):1246-1263. PubMed ID: 29879839 [TBL] [Abstract][Full Text] [Related]
6. Cancer breath testing: a patent review. Kabir KMM; Donald WA Expert Opin Ther Pat; 2018 Mar; 28(3):227-239. PubMed ID: 29297703 [TBL] [Abstract][Full Text] [Related]
7. Volatile signature for the early diagnosis of lung cancer. Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451 [TBL] [Abstract][Full Text] [Related]
8. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis. Zhou J; Huang ZA; Kumar U; Chen DDY Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702 [TBL] [Abstract][Full Text] [Related]
9. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643 [TBL] [Abstract][Full Text] [Related]
10. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study. Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569 [TBL] [Abstract][Full Text] [Related]
11. Exhaled Breath Markers for Nonimaging and Noninvasive Measures for Detection of Multiple Sclerosis. Broza YY; Har-Shai L; Jeries R; Cancilla JC; Glass-Marmor L; Lejbkowicz I; Torrecilla JS; Yao X; Feng X; Narita A; Müllen K; Miller A; Haick H ACS Chem Neurosci; 2017 Nov; 8(11):2402-2413. PubMed ID: 28768105 [TBL] [Abstract][Full Text] [Related]
12. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
13. Sensors for breath testing: from nanomaterials to comprehensive disease detection. Konvalina G; Haick H Acc Chem Res; 2014 Jan; 47(1):66-76. PubMed ID: 23926883 [TBL] [Abstract][Full Text] [Related]
14. Volatile organic compounds in cancer and exhaled breath detection technology. Zhou X; Qi M; Tang M; Wen S; Xue Z; Wang T Adv Clin Chem; 2024; 122():53-114. PubMed ID: 39111965 [TBL] [Abstract][Full Text] [Related]
15. Detection of volatile organic compounds as biomarkers in breath analysis by different analytical techniques. Buszewski B; Grzywinski D; Ligor T; Stacewicz T; Bielecki Z; Wojtas J Bioanalysis; 2013 Sep; 5(18):2287-306. PubMed ID: 24053244 [TBL] [Abstract][Full Text] [Related]
16. Establishing Healthy Breath Baselines With Tin Oxide Sensors: Fundamental Building Blocks for Noninvasive Health Monitoring. Heranjal S; Maciel M; Kamalapally SNR; Ramrakhiani I; Schulz E; Cao S; Liu X; Relich RF; Wek R; Woollam M; Agarwal M Mil Med; 2024 Aug; 189(Suppl 3):221-229. PubMed ID: 39160864 [TBL] [Abstract][Full Text] [Related]
17. On the importance of accurate quantification of individual volatile metabolites in exhaled breath. Smith D; Španěl P J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619 [TBL] [Abstract][Full Text] [Related]
18. Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis. Hanna GB; Boshier PR; Markar SR; Romano A JAMA Oncol; 2019 Jan; 5(1):e182815. PubMed ID: 30128487 [TBL] [Abstract][Full Text] [Related]
19. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121 [TBL] [Abstract][Full Text] [Related]
20. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report. Waltman CG; Marcelissen TAT; van Roermund JGH Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]